Literature DB >> 34394724

A challenging case of hypercapnic respiratory failure during pregnancy.

B Vijayakumar1, M Cao2, L Mackillop3, N Sarangmat2, M I Leite2, C G Wathen4, A H Nickol1, C D Turnbull1.   

Abstract

We describe a 40-year-old female who presented with progressive breathlessness and hypercapnic respiratory failure during pregnancy secondary to undiagnosed muscle-specific kinase myasthenia gravis. Her presentation was progressive and protracted, having over five contacts with healthcare professionals over nine months, many of these predating her pregnancy. Her atypical presentation for myasthenia with minimal limb weakness led to consideration of other causes of hypercapnic respiratory failure. Once diagnosed, she was treated with intravenous immunoglobulin and non-invasive ventilation. She gave birth to a pre-term infant by planned caesarean section. Her insidious presentation and the progressive nature of her breathlessness were unusual and our report highlights the predominant involvement of respiratory muscles in muscle-specific kinase myasthenia. Her pregnancy may have further delayed her diagnosis due the attribution of some symptoms to normal pregnancy. Early recognition and treatment of myasthenia gravis are important to prevent life-threatening complications.
© The Author(s) 2020.

Entities:  

Keywords:  Myasthenia gravis; hypercapnia; pregnancy; respiratory insufficiency

Year:  2020        PMID: 34394724      PMCID: PMC8358241          DOI: 10.1177/1753495X20944707

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  22 in total

1.  Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.

Authors:  F Deymeer; O Gungor-Tuncer; V Yilmaz; Y Parman; P Serdaroglu; C Ozdemir; A Vincent; G Saruhan-Direskeneli
Journal:  Neurology       Date:  2007-02-20       Impact factor: 9.910

Review 2.  Myasthenia Gravis.

Authors:  Nils E Gilhus
Journal:  N Engl J Med       Date:  2016-12-29       Impact factor: 91.245

3.  BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults.

Authors:  A Craig Davidson; Stephen Banham; Mark Elliott; Daniel Kennedy; Colin Gelder; Alastair Glossop; Alistair Colin Church; Ben Creagh-Brown; James William Dodd; Tim Felton; Bernard Foëx; Leigh Mansfield; Lynn McDonnell; Robert Parker; Caroline Marie Patterson; Milind Sovani; Lynn Thomas
Journal:  Thorax       Date:  2016-04       Impact factor: 9.139

Review 4.  Myasthenia gravis.

Authors:  W C Plauché
Journal:  Clin Obstet Gynecol       Date:  1983-09       Impact factor: 2.190

5.  The features of myasthenia gravis with autoantibodies to MuSK.

Authors:  D Lavrnic; M Losen; A Vujic; M De Baets; L J Hajdukovic; V Stojanovic; R Trikic; P Djukic; S Apostolski
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

Review 6.  Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets.

Authors:  Angela Vincent; John Bowen; John Newsom-Davis; John McConville
Journal:  Lancet Neurol       Date:  2003-02       Impact factor: 44.182

7.  Neonatal myasthenia gravis: clinical and immunological study of seven mothers and their newborn infants.

Authors:  E Bartoccioni; A Evoli; C Casali; C Scoppetta; P Tonali; C Provenzano
Journal:  J Neuroimmunol       Date:  1986-08       Impact factor: 3.478

8.  Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity.

Authors:  S Mossman; A Vincent; J Newsom-Davis
Journal:  Lancet       Date:  1986-01-18       Impact factor: 79.321

9.  Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.

Authors:  Amelia Evoli; Pietro A Tonali; Luca Padua; Mauro Lo Monaco; Flavia Scuderi; Anna P Batocchi; Mariapaola Marino; Emanuela Bartoccioni
Journal:  Brain       Date:  2003-06-23       Impact factor: 13.501

Review 10.  International consensus guidance for management of myasthenia gravis: Executive summary.

Authors:  Donald B Sanders; Gil I Wolfe; Michael Benatar; Amelia Evoli; Nils E Gilhus; Isabel Illa; Nancy Kuntz; Janice M Massey; Arthur Melms; Hiroyuki Murai; Michael Nicolle; Jacqueline Palace; David P Richman; Jan Verschuuren; Pushpa Narayanaswami
Journal:  Neurology       Date:  2016-06-29       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.